Assessing RET-Altered Tumors for Personalized Oncology Care, Oct 23

Memo

Join us on Tuesday, October 23 at the Hyatt Regency in Chicago for a dynamic symposium during CAP 2018. Learn about the latest clinical data on selective RET inhibitors along with practical guidance to facilitate the detection of RET alterations from leading pathology experts, Dara L. Aisner, MD, PhD, and Eric Q. Konnick, MD, MS. They will lead discussions and answer your questions on the methodology and testing strategies for RET fusions and mutations. This satellite symposium is complimentary to attend and is CME-certified for 1.5 contact hours. Speakers: Dara L. Aisner, MD, PhD, Eric Q. Konnick, MD, MS Time: 6:00 pm - 8:00 pm Venue details: Hyatt Regency Chicago, 151 East Upper Wacker Drive,Regency AB,60601,Chicago, USA